Monday, August 8, 2016

UPDATE 2-Allergan revenue disappoints as Alzheimer drug loses exclusivity

Aug 8 (Reuters) - Allergan Plc reported

weaker-than-expected quarterly revenue after sales of its

Alzheimer's drug, Namenda IR, collapsed following the loss of

patent exclusivity, and the company cut...

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)